APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline

Vascular dysfunction—The disregarded partner of Alzheimer's disease

(2019) Melanie D. Sweeney et al.   Alzheimers & Dementia

Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction

(2019) Daniel A. Nation et al.   NATURE MEDICINE

Induction of Mesoderm and Neural Crest-Derived Pericytes from Human Pluripotent Stem Cells to Study Blood-Brain Barrier Interactions

(2019) Tannaz Faal et al.   Stem Cell Reports

Pericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss

(2019) Angeliki M. Nikolakopoulou et al.   NATURE NEUROSCIENCE

CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology

(2019) J. S. Miners et al.   Alzheimers Research & Therapy

Undetectable gadolinium brain retention in individuals with an age-dependent blood-brain barrier breakdown in the hippocampus and mild cognitive impairment

(2019) Axel Montagne et al.   Alzheimers & Dementia

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

(2018) Melanie D. Sweeney et al.   Nature Reviews Neurology

Neuroanatomical morphometric characterization of sex differences in youth using statistical learning

(2018) Farshid Sepehrband et al.   NEUROIMAGE

Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer’s disease

(2018) Rachel E. Bennett et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antemortem Pulse Pressure Elevation Predicts Cerebrovascular Disease in Autopsy-Confirmed Alzheimer's Disease

(2018) Daniel A. Nation et al.   JOURNAL OF ALZHEIMERS DISEASE

Widespread distribution of tauopathy in preclinical Alzheimer disease

(2018) Stephanie A. Schultz et al.   NEUROBIOLOGY OF AGING

Efficacy and safety of alisporivir for the treatment of hepatitis C infection

(2018) Carol Stanciu et al.   EXPERT OPINION ON PHARMACOTHERAPY

Alzheimer’s disease: A matter of blood–brain barrier dysfunction?

(2017) Axel Montagne et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Optimal Reference Region to Measure Longitudinal Amyloid-β Change with 18 F-Florbetaben PET

(2017) Santiago Bullich et al.   JOURNAL OF NUCLEAR MEDICINE

AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure

(2017) Shruti Mishra et al.   NEUROIMAGE

The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease

(2017) Costantino Iadecola   NEURON

Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case

(2017) Marta Marquié et al.   Acta Neuropathologica Communications

Neuropsychological Criteria for Mild Cognitive Impairment and Dementia Risk in the Framingham Heart Study

(2016) Amy J. Jak et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging

(2016) Harm J. van de Haar et al.   NEUROBIOLOGY OF AGING

Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease

(2016) Harm J. van de Haar et al.   RADIOLOGY

Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

(2016) Y. Iturria-Medina et al.   Nature Communications

Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease

(2015) Katherine J. Bangen et al.   Alzheimers & Dementia

Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease

(2015) Matthew R Halliday et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Blood-Brain Barrier Breakdown in the Aging Human Hippocampus

(2015) Axel Montagne et al.   NEURON

Shedding of soluble platelet-derived growth factor receptor-β from human brain pericytes

(2015) Abhay P. Sagare et al.   NEUROSCIENCE LETTERS

False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies

(2014) Mark E. Glickman et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Imaging Brain Effects of APOE4 in Cognitively Normal Individuals Across the Lifespan

(2014) Marine Fouquet et al.   NEUROPSYCHOLOGY REVIEW

The APOE ε4/ε4 Genotype Potentiates Vascular Fibrin(Ogen) Deposition in Amyloid-Laden Vessels in the Brains of Alzheimer's Disease Patients

(2013) Karin Hultman et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

(2013) Joanna M Wardlaw et al.   LANCET NEUROLOGY

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

(2013) C. M. Roe et al.   NEUROLOGY

Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

(2012) Robert D. Bell et al.   NATURE

FreeSurfer

(2012) Bruce Fischl   NEUROIMAGE

APOE and Alzheimer disease: a major gene with semi-dominant inheritance

(2011) E Genin et al.   MOLECULAR PSYCHIATRY

Pericytes regulate the blood–brain barrier

(2010) Annika Armulik et al.   NATURE

Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging

(2010) Robert D. Bell et al.   NEURON

Neuroimaging Study Designs, Computational Analyses and Data Provenance Using the LONI Pipeline

(2010) Ivo Dinov et al.   PLoS One

The Alzheimerʼs Disease Centersʼ Uniform Data Set (UDS)

(2009) Sandra Weintraub et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Quantification of Five Neuropsychological Approaches to Defining Mild Cognitive Impairment

(2009) Amy J. Jak et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY